Bioventix's market cap is currently ―. The company's EPS TTM is p1.661; its P/E ratio is 26.04; and it has a dividend yield of 3.65%. Bioventix is scheduled to report earnings on October 28, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 5.15M	£ 6.13M	£ 5.05M	£ 6.49M	£ 5.84M
Total Assets	£ 11.71M	£ 13.12M	£ 10.63M	£ 12.91M	£ 11.21M
Total Debt	£ 0.00	£ 0.00	£ 0.00	£ 0.00	£ 0.00
Net Debt	£ -5.15M	£ -6.13M	£ -5.05M	£ -6.49M	£ -5.84M
Total Liabilities	£ 1.24M	£ 1.30M	£ 900.19K	£ 1.09M	£ 897.97K
Stockholders Equity	£ 10.47M	£ 11.82M	£ 9.73M	£ 11.82M	£ 10.31M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

Bioventix Earnings and Revenue History

Income Statement >

Bioventix Debt to Assets

Balance Sheet >

Bioventix Cash Flow

Cash Flow >

Bioventix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing